Newly-Approved High Dose Eylea Cuts Down on Injection Frequency

The Food And Drug Administration approved a higher dose of Eylea, a drug used to treat wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. Experts say depending on the patient and the severity of their condition,